Roux-en-Y gastric bypass alters tumor necrosis factor-α but not adiponectin signaling in immediate postoperative period in obese rats

Surgery for Obesity and Related Diseases

Volumn 6, Issue 6, 2010, Pages 676-680

  Rideout, Drew A ^a   Peng, Yanhua ^a   Rakita, Steven S ^a   Desai, Karan ^a   Gower Jr , William R ^b   You, Min ^a   Murr, Michel M ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Adiponectin; Gastric bypass; Inflammation; Obesity; Rat; TNF ; Tumor necrosis factor

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 2; KETOPROFEN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL EUTHANASIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; LIPID DIET; LIVER; MALE; NONHUMAN; OBESITY; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROUX Y ANASTOMOSIS; SHAM PROCEDURE; SIGNAL TRANSDUCTION;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; DISEASE MODELS, ANIMAL; GASTRIC BYPASS; INFLAMMATION; LIVER; MALE; OBESITY; POSTOPERATIVE PERIOD; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADIPONECTIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649514869     PISSN: 15507289     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soard.2010.05.017     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention Behavioral risk factor surveillance system survey data 2007 U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Atlanta, Georgia
2. H. Buchwald, Y. Avidor, and E. Braunwald Bariatric surgery: a systematic review and meta-analysis JAMA 292 2004 1724 1737
3. M. Faraj, P.J. Havel, S. Phelis, D. Blank, A.D. Sniderman, and K. Cianflone Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects J Clin Endocrinol Metab 88 2003 1594 1602
4. C. Rogers, J. Ajmo, and M. You Adiponectin and alcoholic fatty liver disease IUBMB Life 60 2008 790 797
5. S.E. Shoelson, L. Herrero, and A. Naaz Obesity, inflammation, and insulin resistance Gastroenterology 132 2007 2169 2180
6. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867
7. Y. Peng, D. Rideout, and S. Rakita Downregulation of adiponectin/adipoR2 is associated with steatohepatitis in obese mice J Gastrointest Surg 13 2009 2043 2049
8. D.A. Rideout, Y. Peng, S.S. Rakita, W.R. Gower, M. You, and M.M. Murr Roux-en-Y gastric bypass downregulates hepatic stearoyl-CoA desaturase 1 independently of serum leptin in obese rats J Surg Res 151 2009 244
9. D.A. Rideout, S.S. Rakita, Y. Peng, W.R. Gower, and M.M. Murr Practical considerations and survival techniques for a rat model of Roux-en-Y gastric bypass Gastroenterology 134 2008 A877
10. D. Cai Local and systemic insulin resistance resulting from hepatic activation of IKKb and NF-KB Nature Med 11 2005 183 190
11. J.G. Kral, S.N. Thung, and S. Biron Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis Surgery 135 2004 48 58
12. S.G. Mattar, L.M. Velcu, and M. Rabinovitz Surgically-induced weight loss significantly improves NAFLD and the metabolic syndrome Ann Surg 242 2005 610 617
13. K. Nagata, H. Suzuki, and S. Sakaguchi Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or acoholic steatohepatitis J Toxicol Sci 32 2007 453 468
14. Y. Peng, S. Gallagher, R. Landmann, and M. Murr The role of p65NF-kappaB/RelA in pancreatitis-induced Kupffer cells apoptosis J Gastrointest Surg 10 2006 837 847
15. Y. Peng, C. Sigua, D. Rideout, and M. Murr Deletion of toll-like receptor-4 downregulates protein kinase C-zeta and attenuates liver injury in experimental pancreatitis Surgery 143 2008 679 685
16. Y. Peng, C. Sigua, C. Karsonovich, and M. Murr Protein kinase C-zeta regulates Kupffer cell apoptosis during experimental sepsis J Gastrointest Surg 11 2007 1712 1721
17. T. Kadowaki, T. Yamauchi, N. Kubota, H. Hara, K. Ueki, and K. Tobe Adiponectin and adiponectin receptors in insulin resistance, diabetes and metabolic syndrome J Clin Invest 116 2006 1784 1792
18. S.D. Dubois, L.K. Heilbronn, S.H. Smith, J.B. Albu, D.E. Kelley, and E. Ravussin Decreased expression of adipogenic genes in obese subjects with type 2 diabetes Obesity 14 2006 1543 1552
19. N. Yamaguchi, J.G. Argueta, and Y. Masuhiro Adiponectin inhibits toll-like receptor family-induced signaling FEBS Lett 579 2005 6821 6826
20. A. Xu, Y. Wang, and H. Keshaw The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice J Clin Invest 112 2003 91 100
21. M.M. Swarbrick, I.T. Austrheim-Smith, and K.L. Stanhope Circulating concentrations of high-molecular weight adiponectin are increased following Roux-en-Y gastric bypass surgery Diabetologia 49 2006 2552 2558
22. Y. Peng, D.A. Rideout, and S.S. Rakita Roux-en-Y gastric bypass reduces oxidative stress and downregulates pro-inflammatory genes in livers of obese rats and in Kupffer cells via an AMPK-dependent pathway J Surg Res 151 2009 244 245